(The below are key points I pulled from rea­ding Jef­fries book. At the end of each sentence/paragraph is a num­ber which repre­sents the page. Of course, there is much more in the book, but these stood out to me. If you want to read the entire book your­self, go to the Publisher’s web­site to order the paper­back: http://www.ccthomas.com/details.cfm?P_ISBN=039807500X It’s expen­sive for a paper­back, but the price is half of what you would get it anywhere else. Enjoy the below! It blew me away. Janie)

SAFE USES OF CORTISOL by William McK. Jef­fries 3rd Edition

Chap­ter 1-Background

The first chap­ter dis­cus­ses the his­tory of our know­ledge of cor­ti­sone and cor­ti­sol. In 1929, Dr. Hench figu­red out that rheu­ma­toid arth­ri­tis disap­pea­red because of a nor­mal adre­no­cor­ti­cal res­ponse after sur­gery, preg­nancy and other situa­tions. They didn’t multi-dose then, and used much lar­ger amounts than nee­ded. We now know that sma­ller dosa­ges of cor­ti­sone or cor­ti­sol are effec­tive and may take ten to 14 days to pro­duce impres­sive impro­ve­ment in arth­ri­tis. Because they used such large doses of cor­ti­sol in treat­ment, side effects occu­rred, and the pre­sump­tion was made that any dosage of any glu­co­cor­ti­coid would have poten­tially hazar­dous and unde­si­ra­ble effects. “For over thirty years, phy­si­cians have been indoc­tri­na­ted with this concept.”

Chap­ter 2

1) It is not gene­rally rea­li­zed that the dan­ge­rous side effects of glu­co­cor­ti­coid the­rapy occur only with cer­tain dosa­ges and not with others. That there is a tre­men­dous dif­fe­rence bet­ween the effects of small “phy­sio­lo­gic” dosa­ges and those of lar­ger “phar­ma­co­lo­gic” dosa­ges (lar­ger than 40mg) has not been empha­si­zed. 11 When applied to hor­mone actions, a “phy­sio­lo­gic” dosage implies one that pro­mo­tes nor­mal func­tion, whe­reas a “phar­ma­co­lo­gic” dosage is one in excess of nor­mal requi­re­ments and hence, one that might alter nor­mal func­tion. 12

2) Phy­sio­lo­gic stu­dies indi­cate that the ave­rage daily pro­duc­tion of cor­ti­sol by human adre­nals under basal con­di­tions is appro­xi­ma­tely 15 – 20 mg, but this dosage will not main­tain a totally adre­na­lec­to­mi­zed patient. 35 – 40 mg daily is neces­sary to inhi­bit endo­ge­nous adre­nal ste­roid pro­duc­tion to zero, and this dosage will satis­fac­to­rily main­tain an adre­na­lec­to­mi­zed patient with a mini­mum of sup­ple­men­tary sodium-retaining ste­roid. Taken by mouth, even in divi­ded doses, cor­ti­sone ace­tate or cor­ti­sol is only approx. 60% as effi­cient as when the hor­mone is natu­rally pro­du­ced by the adre­nals or relea­sed directly into the blood. 13 (the last sta­te­ment makes you won­der about doing cor­ti­sol sublin­gually! Janie)

3) It has been demons­tra­ted that when sub­jects with intact adre­nals receive less than full repla­ce­ment dosa­ges of cor­ti­sol, endo­ge­nous adre­nal func­tion is sup­pres­sed only suf­fi­ciently to achieve a nor­mal glu­co­cor­ti­coid level. For exam­ple, sub­jects recei­ving 20 mg (5 mg. four times) daily of cor­ti­sol have their endo­ge­nous adre­nal ste­roid pro­duc­tion dec­rea­sed by approx. 60%, and sub­jects recei­ving 10 mg. (2.5 mg. four times) daily have their adre­nal ste­roid pro­duc­tion dec­rea­sed by approx. 30%. The resi­dual func­tio­ning tis­sue is ade­quate for appa­rently nor­mal res­pon­ses to stres­ses such as res­pi­ra­tory or gas­troin­tes­ti­nal infec­tions or even major sur­gery, but because their hypothalamus-pituitary-adrenal (HPA) res­ponse to stress might be impai­red, and because of recent evi­dence that at least some autoim­mune disor­ders are asso­cia­ted with a defec­tive HPA res­ponse to stress, it seems advi­sa­ble to sup­ple­ment their cor­ti­sol dosa­ges at times of any inc­rea­sed stress and espe­cially at times of sur­gery or simi­lar severe stress as in patients with more severe adre­no­cor­ti­cal defi­ciency. 14

Subre­pla­ce­ment dosa­ges also avoid the com­plete sup­pres­sion of endo­ge­nous adre­nal andro­gen pro­duc­tion that pro­bably cau­ses a higher inci­dence in women than in men of unde­si­ra­ble side effects such as osteo­po­ro­sis when lar­ger dosa­ges are taken for long periods. Many patients who need subre­pla­ce­ment dosa­ges have low adre­nal reserve, so the admi­nis­tra­tion of such dosa­ges actually impro­ves the adre­nals’ abi­lity to res­pond to stress in these cases. 14

4) The sche­dule of admi­nis­te­ring cor­ti­sol every eight hours or four times daily is follo­wed because of evi­dence that nor­mal blood levels and some meta­bo­lic effects of a sin­gle dose of cor­ti­sol do not last lon­ger than 8 hours. For prac­ti­cal pur­po­ses, divi­ding the total daily dosage into four parts taken before each meal and at bed­time has two advan­ta­ges. It is easier for a patient to remem­ber to take a medi­ca­tion at these times than at other times, and the inges­tion of food tends to coun­te­ract the deve­lop­ment of acid indi­ges­tion from the cor­ti­sol. For the bed­time dose, patients are ins­truc­ted to drink milk or take an anta­cid with the medi­ca­tion. 15 – 16 (from Janie – In Wilson’s book, Adre­nal Fati­gue 21st Cen­tury, he recom­mends the follo­wing: 12 mg. first thing in the mor­ning, then 5 mgs at noon, then 2 mgs at 3 pm, and finally 1 mg at 6 pm. That bet­ter follows the nor­mal rhythm.)

5) Why should most phy­si­cians be una­ware of the safety of small phy­sio­lo­gic dosa­ges?
1. There has been no pro­mo­tion of phy­sio­lo­gic dosa­ges by phar­ma­ceu­ti­cal com­pa­nies.
2. There has been little, if any, disc­ri­mi­na­tion bet­ween the effects of phy­sio­lo­gic vs. phar­ma­co­lo­gic dosa­ges.
3. There is a ten­dency to con­fuse cor­ti­sone and cor­ti­sol with there more potent deri­va­ti­ves, such as pred­ni­sone, pred­ni­so­lone, dex, etc. 18 – 19

Chap­ter 3– The Sig­ni­fi­cance of Nor­mal Adre­no­cor­ti­cal Function

6) Four known types of ste­roids of the cor­tex are: glu­co­cor­ti­coid, mine­ra­lo­cor­ti­coid (aldos­te­rone), andro­gen, and estro­gen, (plus an unk­nown pro­ba­ble other).,

Glu­co­cor­ti­coid has one of its chief actions sti­mu­la­tion of the for­ma­tion of glu­cose from non-carbohydrate sour­ces such as amino acids from pro­tein, a pro­cess known as glu­co­neo­ge­ne­sis. This is a vital effect in the main­te­nance of nor­mal levels of blood glu­cose when food intake is irre­gu­lar, since low blood sugar is incom­pa­ti­ble with nor­mal func­tion of the brain, musc­les or other tis­sues. 25 – 26

7) It has been recog­ni­zed for many years that patients with adre­nal insuf­fi­ciency not only are more sus­cep­ti­ble to low levels of serum sodium, with resul­ting hypo­ten­sion and shock, but are also more sus­cep­ti­ble to patho­lo­gic sodium reten­tion from exces­sive amounts of salt or of sodium-retaining ste­roids, such as aldos­te­rone, desoxy­cor­ti­cos­te­rone, or 9-alpha-fluorohydrocortisone, sug­ges­ting that the adre­nals might pro­duce a subs­tance that pro­tects against sodium reten­tion. 27

8) Two hor­mo­nes pro­du­ced nor­mally by the ova­ries, pro­ges­te­rone and 17-hydrozyprogesterone, have been demons­tra­ted to have natriu­re­tic pro­per­ties (from Janie: cau­sing salt to be eli­mi­na­ted from the body through urine, lowe­ring blood pres­sure) and they are known inter­me­diary ste­roids in adre­nal cor­ti­ces in the path­way of pro­duc­tion of cor­ti­sol, occu­rring in excess in cer­tain types of con­ge­ni­tal adre­nal hyper­pla­sia, but the pos­si­bi­lity that they might aid in nor­mal water balance has appa­rently not been inves­ti­ga­ted. 27

9) A per­son who sleeps from 11 pm to 7 am has a maxi­mum level of cor­ti­sol in his or her blood at approx. 8 am, then it gra­dually dec­rea­ses through the day and eve­ning, reaching a low point at approx. 1 am, follo­wing which it inc­rea­ses pro­gres­si­vely during sleep to reach it’s max again at 8 am. The peak daily level of plasma-cortisol in a nor­mal indi­vi­dual is usually bet­ween 20 and 30 mcg and the lowest level is bet­ween 5 and 10 mcg. 28

10) The pro­duc­tion of cor­ti­sol is pri­ma­rily regu­la­ted by the pro­duc­tion of ACTH/corticotrophin by the pitui­tary, which is in turn con­tro­lled by the pro­duc­tion of corticotrophin-releasing fac­tor (CRF) by the hypotha­la­mus. The pro­duc­tion of DHEA seems to be only partly regu­la­ted by ACTH, but its
con­trol is less well understood.

11) A patient with untrea­ted mild adre­nal insuf­fi­ciency or low adre­nal reserve may func­tion rea­so­na­ble well when envi­ron­men­tal con­di­tions are opti­mum but tends to tire more easily, and if stre­nuous phy­si­cal exer­cise is under­ta­ken or a meal skip­ped, hypogly­ce­mic symp­toms may deve­lop. If an infec­tion such as a com­mon cold deve­lops, symp­toms tend to be more severe and last lon­ger than in a per­son with nor­mal adre­no­cor­ti­cal reserve. These unde­si­ra­ble deve­lop­ments may be pre­ven­ted by admi­nis­tra­tion of sui­ta­ble, safe, phy­sio­lo­gic dosa­ges of cor­ti­sol. It has also been demons­tra­ted that nor­mal adre­no­cor­ti­cal func­tion is essen­tial for opti­mum abi­lity to withs­tand infec­tions, nume­rous stu­dies having indi­ca­ted that either too little or too much glu­co­cor­ti­coid can impair resis­tance to infec­tion, whe­reas an opti­mum level of cor­ti­sol enhan­ces resis­tance to infec­tion. 29

12) It is sug­ges­ted that adre­nal pro­duc­tion of glu­co­cor­ti­coids is rela­ted to body size and fat com­po­si­tion. 31

Chap­ter 4 — GENERALLY ACCEPTED USES OF PHYSIOLOGIC DOSAGES

13) Adre­nal insuf­fi­ciency can be mani­fes­ted by hyper­pig­men­ta­tion of the skin, weak­ness, fati­gue, ano­re­xia, and sus­cep­ti­bi­lity to collapse and shock with expo­sure to stress. Adre­nal insuf­fi­ciency resul­ting from an autoim­mune phe­no­me­non have become more com­mon diag­no­ses. 33

14) When cor­ti­sone and ACTH became avai­la­ble for human use in 1948, these hor­mo­nes first attrac­ted world­wide atten­tion by their dra­ma­tic bene­fi­cial effects on patients with rheu­ma­toid arth­ri­tis. The dosa­ges emplo­yed were large, howe­ver and pro­du­ced catas­trophic side effects.…33

15) Meanwhile, expe­rience with the use of small, safe, phy­sio­lo­gic dosa­ges of cor­ti­sol in patients with ova­rian dys­func­tion and infer­ti­lity revea­led that patients with asso­cia­ted aller­gies, chro­nic fati­gue or autoim­mune disor­ders also repor­ted impro­ve­ment in these con­di­tions while taking the ste­roid, without expe­rien­cing any unde­si­ra­ble side effects. These results were published in a lea­ding medi­cal jour­nal, but the repu­ta­tion of glu­co­cor­ti­coids had become so bad that they recei­ved little atten­tion. 34

16) Hence, the diag­no­sis and treat­ment of mild adre­no­cor­ti­cal defi­ciency, a con­di­tion that is rarely men­tio­ned in medi­cal text­books, has become impor­tant for all prac­ti­cing phy­si­cians to recog­nize. It may be pri­mary, resul­ting from ina­de­quate pro­duc­tion of cor­ti­sol by the adre­nals and some­ti­mes ter­med “low adre­nal reserve”, or it may be secon­dary to ina­de­quate sti­mu­la­tion of the adre­nals by ACTH from the pitui­tary or by cor­ti­co­trophin relea­sing fac­tor (CRF) from the hypotha­la­mus. Another pos­si­ble cause of symp­toms of cor­ti­sol defi­ciency is a defect in the cellu­lar recep­tors (i.e. cellu­lar resis­tance) for cor­ti­sol cau­sing asso­cia­ted nor­mal or ele­va­ted levels of plasma cor­ti­sol. 34

17) Recent reports have pre­sen­ted evi­dence that patients with rheu­ma­toid arth­ri­tis and seve­ral other autoim­mune disor­ders have abnor­mal res­pon­ses of the HPA axes to stress, so the pos­si­bi­lity that the deve­lop­ment of these disor­ders might be rela­ted to defec­tive HPA res­pon­ses seems likely. This would explain the bene­fi­cial effects of small, phy­sio­lo­gic dosa­ges of cor­ti­sol that have been obser­ved in some of these patients and sup­port the advi­sa­bi­lity of tes­ting the inte­grity of this axis and the use of the­ra­peu­tic trials with safe, phy­sio­lo­gic dosa­ges of cor­ti­sol in patients with these disor­ders. 35

18 } It is pre­fe­ra­ble to have these tests run in the mor­ning after the patient has had ade­quate sleep and has not taken for a suf­fi­cient inter­val of time any glu­co­cor­ti­coid or other medi­ca­tion that might affect adre­nal func­tion or blood levels of cor­ti­sol, but help­ful infor­ma­tion can be obtai­ned by run­ning them at any time of day. A more sen­si­tive low dose Cor­trosyn test (what we call the STIM test — Janie) has been sug­ges­ted for the diag­no­sis of mild adre­nal defi­ciency, but because the­ra­peu­tic trials are usually jus­ti­fied, even in patients with appa­rently nor­mal tests, some­ti­mes it is pre­fe­ra­ble to delay further tes­ting until a the­ra­peu­tic trial has been made, espe­cially if it might avoid other­wise unne­ces­sary hos­pi­ta­li­za­tion. 36

19) It is impor­tant to be aware that test results that fall within the “nor­mal range” do not rule out the pos­si­bi­lity that a patient might have mild adre­nal defi­ciency since the nor­mal range was pro­bably obtai­ned from a group of peo­ple who did not have clas­si­cal Addison’s disease or hypo­pi­tui­ta­rism or any other known phy­si­cal disor­der and is rather broad. Hence, it might inc­lude per­sons with chro­nic aller­gies or other con­di­tions that may be asso­cia­ted with mild adre­nal defi­ciency. Further­more, as pre­viously men­tio­ned, mild adre­nal defi­ciency can occur secon­dary to ina­de­quate sti­mu­la­tion by ACTH from the pitui­tary or by CRF from the hypotha­la­mus. These patients have low nor­mal base­line blood cor­ti­sol levels that res­pond nor­mally to Cor­trosyn, but still improve with phy­sio­lo­gic dosage of cor­ti­sol. Hence, results of Cor­trosyn tests within the nor­mal range do not exc­lude the pos­si­bi­lity that patients might bene­fit from cor­ti­sol the­rapy, so a the­ra­peu­tic trial might still be jus­ti­fied. 36

20) The base­line cor­ti­sol test is an exam­ple of the impos­si­bi­lity of having strict end points in desig­na­ting nor­mal ran­ges of hor­mone levels, espe­cially for a dyna­mic hor­mone such as cor­ti­sol, whose levels may fluc­tuate from minute to minute depen­ding upon the degree of stress in addi­tion to diur­nal varia­tion. Hence, patients with adre­nal insuf­fi­ciency may have plasma cor­ti­sol levels within low nor­mal range, espe­cially in the after­noon and eve­ning, and patients with hype­ra­dre­na­lism may have plasma cor­ti­sol levels within upper nor­mal range in the mor­ning. It is there pos­si­ble that mil­der degrees of low adre­nal reserve may not be detec­ted unless Cor­trosyn tests are per­for­med in the mor­ning at a time when base­line cor­ti­sol levels are maxi­mum. Further­more, patients vary in the sus­cep­ti­bi­lity to various degrees of stress, inc­lu­ding the stress of having injec­tions and blood tests, so these fac­tors must be con­si­de­red in inter­pre­ting the results of tests. Hence, a diag­no­sis of mild adre­no­cor­ti­cal defi­ciency should depend pri­ma­rily on the cli­ni­cal pic­ture and the­ra­peu­tic trials are often jus­ti­fied even when the results of tests fall within the nor­mal range. 37

21) It should be empha­si­zed that a “nor­mal” base­line plasma cor­ti­sol and res­ponse to Cor­trosyn does not rule out the pos­si­bi­lity that a patient might improve with a phy­sio­lo­gic dosage of cor­ti­sol, so for patient with disor­ders that sug­gest the pos­si­bi­lity of mild adre­nal defi­ciency, the­ra­peu­tic trials with a small, subre­pla­ce­ment dosage of cor­ti­sol might still be help­ful. 38

22) Because spon­ta­neous adre­nal insuf­fi­ciency results from pro­gres­sive des­truc­tion of adre­nal tis­sue, symp­toms appear when the pro­cess reaches the point where remai­ning adre­nal tis­sue is insuf­fi­cient to main­tain nor­mal well-being. This may require des­truc­tion of over 90% of the glan­du­lar tis­sue, but the rem­nant is capa­ble of some func­tion, so repla­ce­ment dosa­ges of cor­ti­sol in chro­nic adre­nal insuf­fi­ciency are usually less than the 35 – 40 mg daily that are requi­red for the totally adre­na­lec­to­mi­zed patients. Most patients can be main­tai­ned on bet­ween 20 and 30 mgs. daily in divi­ded doses. Although some patients may feel well on less than 20 mg. daily, it seems pre­fe­ra­ble to give at least this much cor­ti­sol, even to patients with low adre­nal reserve, because it takes the strain off of the resi­dual adre­nal tis­sue and pro­vi­des for more func­tio­nal reserve in times of stress. Under some cir­cums­tan­ces, it appears to pro­vide an oppor­tu­nity for resi­dual tis­sue to rege­ne­rate. A few patients with low reserve have demons­tra­ted evi­dence of reco­very of reserve after months of even years of such treat­ment, but most seem to require some repla­ce­ment for the remain­der of their lives. 39

23) Widely recom­men­ded is 2/3rds of the daily dosage before break­fast and 1/3 after sup­per, but patients have pre­fe­rred four divi­ded doses. This is not sur­pri­sing in view of the evi­dence that the half-life of cor­ti­sol in the blood is only 100 minu­tes, and some meta­bo­lic effects of even large doses do not last lon­ger than 8 hours. Four divi­ded doses pro­duce more energy and less fati­gue. 39 – 40

24) Although a lower dosage at sup­per time is logi­cal and seems to dimi­nish a ten­dency to insom­nia that occurs in some patients, a lower dosage at bed­time is not always desi­ra­ble because with nor­mal diur­nal varia­tion the plasma cor­ti­sol level rises during sleep to reach a peak shortly after awa­ke­ning in the mor­ning. It also results in a need to get up and void once or twice during the night. 41

25) Patients with chro­nic adre­no­cor­ti­cal defi­ciency can usually be well main­tai­ned with cor­ti­sol, 5 or 7.5 mg orally before each meal and at bed­time. 41

26) Pac­kage inserts for cor­ti­sol still do not men­tion the dif­fe­ren­ces bet­ween phy­sio­lo­gic and phar­ma­co­lo­gic dosa­ges and effects, impl­ying that any of the many alar­ming side-effects that are lis­ted may occur. 42 – 43

27) When a patient with adre­nal insuf­fi­ciency encoun­ters stress, addi­tio­nal cor­ti­sol is neces­sary to main­tain nor­mal health and sense of well-being. 41 Higher dosa­ges of cor­ti­sol are requi­red to main­tain a phy­sio­lo­gic state that would pro­duce hyper­cor­ti­so­lism with it’s well-known unde­si­ra­ble effects in the uns­tres­sed sta­tes. The inc­rea­sed sec­re­tion of adre­nal hor­mo­nes ser­ves to meet an inc­rea­sed need during stress and trends to main­tain homeos­ta­sis rather than to dis­turb it. The inc­rea­sed sec­re­tion does not cause a state of hyper­cor­ti­cism such as deve­lops when the titer of these hor­mo­nes is inc­rea­sed arti­fi­cially in the absence of need. Hence, a patient with adre­nal insuf­fi­ciency under stress may require dosa­ges of cor­ti­sol to main­tain a phy­sio­lo­gic state that would pro­duce hyper­cor­ti­so­lism with its well-known unde­si­ra­ble effects in the uns­tres­sed state. 44 – 45

28) Patients with adre­nal insuf­fi­ciency should be cau­tio­ned to carry ID cards sta­ting their diag­no­sis, treat­ment, etc.

29) In some res­pects, patients taking cor­ti­sol seem to be healthier than many per­sons without adre­nal insuf­fi­ciency in that they often appear to have more energy, less fati­gue, and a grea­ter resis­tance to at least some types of infec­tion. 46

MILD ADRENOCORTICAL DEFICIENCY

30) As men­tio­ned pre­viously, mild adre­no­cor­ti­cal defi­ciency, either pri­mary (low adre­nal reserve) or secon­dary to ina­de­quate sti­mu­la­tion by the pitui­tary or the hypotha­la­mus is another cli­ni­cal disor­der in which phy­sio­lo­gic dosa­ges of cor­ti­sol have a ratio­nal roles in the­rapy. Low adre­nal reserve is cha­rac­te­ri­zed by a sub­nor­mal res­ponse to ACTH with base­line plasma cor­ti­sol level within nor­mal range. Because of their resi­dual adre­no­cor­ti­cal func­tion, patients with this disor­der can some­ti­mes omit the bed­time dose of cor­ti­sol. Mild secon­dary adre­no­cor­ti­cal defi­ciency is cha­rac­te­ri­zed by a base­line plasma cor­ti­sol level either low or in the low nor­mal range, but with a nor­mal res­ponse to Cor­trosyn sti­mu­la­tion. 54

31) “Thirty-six years ago, I repor­ted the bene­fi­cial effects of phy­sio­lo­gic dosa­ges of cor­ti­sone ace­tate or cor­ti­sol on two patients with rheu­ma­toid arth­ri­tis, with evi­dence that patients with rheu­ma­toid arth­ri­tis see­med to have lower exc­re­tion of dehy­droe­pian­dros­te­rone in their urine and, hence, might have a mild abnor­ma­lity of ste­roid meta­bo­lism. A review of the lite­ra­ture fails to reveal any attempts by others to con­firm these obser­va­tions or even any com­ment on them. The bene­fit of low dosage glu­co­cor­ti­coid the­rapy in meno­pau­sal arth­ri­tis is exem­pli­fied in Case 6 in Chap­ter 4, and patients with other nons­pe­ci­fic types of arth­ri­tis have repor­ted impres­sive impro­ve­ment in arth­ri­tic symp­toms when this treat­ment was admi­nis­te­red for asso­cia­ted pro­blems.” (Five detai­led case his­to­ries follow) 90

32) Because of the onset and aggra­va­tion of rheu­ma­toid arth­ri­tis after periods of inc­rea­sed stress, it is pro­bably impor­tant not only to inc­rease the dosage of cor­ti­sol com­men­su­rate with the degree of inc­rea­sed stress, but also, as soon as opti­mum bene­fit is obtai­ned, to taper the dosage to main­te­nance levels as quickly as pos­si­ble without cau­sing a return of symp­toms. 100

Chap­ter 7 — ALLERGIC DISORDER

33) Patients with sea­so­nal aller­gies may bene­fit from taking small, phy­sio­lo­gic dosa­ges of cor­ti­sol in the spring or autumn, with tem­po­rary inc­rea­ses depen­ding upon the seve­rity of symp­toms. 110

34) Patients who were recei­ving phy­sio­lo­gic dosa­ges of cor­ti­sol began to report that they see­med to get fewer colds than other mem­bers of their fami­lies, often esca­ping com­ple­tely when ever­yone else in the family had been ill. 128

35) A pos­si­ble expla­na­tion of the con­tras­ting effects of phy­sio­lo­gic vs. phar­ma­co­lo­gic dosage of glu­co­cor­ti­coids upon resis­tance to res­pi­ra­tory infec­tions might be as follows: Nor­mally the body main­tains levels of cor­ti­sol and immune glo­bu­lins suf­fi­cient to pro­tect against ave­rage daily expo­sure to infec­tion. The lowe­ring of resis­tance that follows various stres­ses such as exces­sive fati­gue, lack of sleep, or emo­tio­nal upset is accom­pa­nied by a rela­tive defi­ciency of cor­ti­sol that cau­ses malaise and ano­re­xia, and evi­dence of infec­tion deve­lops. When the per­son is able to pro­duce suf­fi­cient anti­bo­dies and other com­po­nents of the immune res­ponse, the infec­tion sub­si­des and symp­toms clear. The mobi­li­za­tion of at least some of the com­po­nents of the immune res­ponse may depend upon the pre­sence of ade­quate cor­ti­sol, since adre­nally insuf­fi­cient sub­jects are not able to pro­duce a nor­mal immune res­ponse. Hence, admi­nis­tra­tion of phy­sio­lo­gic dosa­ges of cor­ti­sol may help to pre­vent the lowe­ring of resis­tance that ena­bles an infec­tion to start or, after an infec­tion has star­ted, may assist the immune res­ponse and ena­ble the per­son to reco­ver more quickly. If, howe­ver, an exces­sive amount of glu­co­cor­ti­coid is pre­sent before an infec­tion deve­lops, the immune res­ponse may be bloc­ked or mis­di­rec­ted, allo­wing infec­tions to deve­lop and pro­gress abnor­mally. It is tem­ping to spe­cu­late that the appa­rent bene­fi­cial effect of vita­min C in the com­mon cold may be media­ted at least in part through the adre­nals, since the highest con­cen­tra­tion of ascor­bic acid in the body occurs in the adre­nal cortex.

VIRAL INFECTIONS

36) Patients with acute influenza were trea­ted in the same man­ner in which patients with chro­nic adre­nal insuf­fi­ciency were trea­ted when they deve­lo­ped acute infec­tions. Cor­ti­sol, 20 mg. by mouth four times daily before meals and at bed­time, was star­ted. Patients were ins­truc­ted to con­ti­nue this dosage until they felt well, then dec­rease to 10 mg. four times daily for two days, then 5 mgs.four times daily for two days, then stop­ped. Cli­ni­cal res­pon­ses were stri­king. Within 24 hours, all patients felt much bet­ter, and within 48 hours symp­toms such as fever, malaise, and gene­ra­li­zed aching had com­ple­tely sub­si­ded, and they felt quite well. The ini­tial dosage of cor­ti­sol was dec­rea­sed after 48 hours and dis­con­ti­nued after six days of the­rapy. No relapse or com­pli­ca­tions occu­rred. 136

37) For many years, it has been recog­ni­zed that the cli­ni­cal symp­toms of acute malaise, ano­re­xia, fever, weak­ness, exhaus­tion, and gene­ra­li­zed aching that occur with any acute severe infec­tion, but espe­cially with influenza, are simi­lar to the symp­toms of acute adre­nal insuf­fi­ciency. 138 The pos­si­bi­lity that a rela­tive defi­ciency of adre­nal res­ponse might be pre­sent in the inci­pient phase of any infec­tious disease should the­re­fore be further inves­ti­ga­ted. 139

38) We now know that influenza viru­ses attack the human body by dec­rea­sing the pro­duc­tion of adre­no­cor­ti­co­tro­pic hor­mo­nes (ACTH), the­reby dec­rea­sing the pro­duc­tion of cor­ti­sol, the only hor­mone that is abso­lu­tely essen­tial for life, so treat­ment with phy­sio­lo­gic dosa­ges of cor­ti­sol is a safe and bene­fi­cial the­rapy for patients with influenza, regard­less of its type. 143

Stop the Thyroid Madness - The Book

Want all the STTM web­site infor­ma­tion plus more details?

Don’t want to be tied to a computer?

Check out infor­ma­tion plus orde­ring details on the most infor­ma­tive, life-changing and only patient-to-patient book on the mar­ket: Stop the Thy­roid Mad­ness book here.

All books orde­red directly from the publishing com­pany will con­tain a book­mark of upda­ted information!

Do NOT follow this link or you will be banned from the site!